相关实验视频

Updated: Jul 17, 2025

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

基因组和外体宽关联研究揭示了与DaTscan成像特征相关的候选基因

Arash Yaghoobi¹, Homa Seyedmirzaei^2,3, Moein Ala⁴

¹Institute for Research in Fundamental Sciences (IPM), School of Biological Sciences, Tehran, Iran.

Parkinson's disease

|September 4, 2023

概括

这项研究使用DaTscan成像识别了潜在的帕金森病 (PD) 遗传联系. 在IGFN1和MAP2K4基因的变异可能会影响PD风险和进展.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
医疗成像医学成像

背景情况:

帕金森病 (PD) 的遗传基础在很大程度上仍然未知,尽管在识别风险位置方面取得了进展.
结合先进的成像技术的内类型方法,为PD的遗传发现提供了新的途径.

研究的目的:

使用内型方法识别与帕金森病相关的新型遗传变异.
通过使用脑脊液 (CSF) 蛋白质组数据,研究已识别的基因变异与PD进展的关联.

主要方法:

在帕金森病进展标志物倡议 (PPMI) 队列的DaTscan成像数据上进行了全外体和全基因组关联研究 (EWAS和GWAS).
单核酸多态 (SNPs) 和插入删除突变 (INDELs) 与多巴胺载体 (DaT) 特定结合比率 (SBRs) 相比进行了分析.
研究了候选基因的CSF蛋白水平与PD进展的关联.

主要成果:

1q32.1上的一个SNP (rs201465075) 与左尾状DaTscanSBR (P=4.03×10−7) 有意义地相关.
17p.12上的一个SNP (rs12450112) 与右前骨有显著的关联DaTscan SBR (P=1.34×10−6).
这些SNP分别与IGFN1和MAP2K4基因有关. 在CSF中MAP2K4蛋白水平与PD进展相关.

结论:

特定的IGFN1和MAP2K4基因变异可能与帕金森病有关.
研究结果表明,这些基因在PD病变发生和进展中可能发挥作用.
需要进一步的实验性研究来验证,考虑到DaTscan在其他帕金森综合征中的潜力.

更多相关视频

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...